Clinical Trials Directory

Trials / Unknown

UnknownNCT00154570

24 Hour Esophageal and Electrogastrography to Investigate the Mechanism of Reflux Esophagitis

Integrating Simultaneous Recording of 24 Hour Esophageal pH and Electrogastrography to Investigate the Mechanism of Reflux Esophagitis

Status
Unknown
Phase
Study type
Observational
Enrollment
50 (planned)
Sponsor
National Taiwan University Hospital · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Accepted

Summary

We hypothesize that gastric dysrhythmias may predispose the occurrence of gastroesophageal reflux.

Detailed description

Gastroesophageal regurgitation with acid is considered the main cause of reflux esophagitis, but the current theory of transient relaxation of LES (TLESR) fails to explain all the mechanisms of reflux esophagitis, for a rather high proportion of reflux esophagitis patients has concomitant other functional gastrointestinal disorder, particularly gastric motility dysfunction. Thus, these patients could even not effectively respond to proton pump inhibitor alone. Abnormal gastric emptying and antral dysmotility has been considered related to reflux esophagitis. EGG is a promising noninvasive tool in study of gastric electric activity and motility, and the application of gastric electric stimulation (GES) in the modulation of gastric motility disorder and even reflux esophagitis has been in proceeding; however, there is lacking study by using EGG to integrate gastric electrical potentials, gastric motility and gastroesophageal reflux in investigating the mechanism of reflux esophagitis till now; especially, no known literature by combined simultaneous prolong ambulatory esophageal pH and EGG recordings has been reported. It has been known in EGG study that gastric dysrhythmias (tachy- and brady-) related smooth muscle function of stomach and dysfunctional gastric emptying. In a preliminary findings of simultaneous prolong ambulatory esophageal pH and EGG recordings by our study group, we found that gastroesophageal reflux with acid tends in the status of abnormal RSA. Thus, we propose the following hypotheses: (1) Gastric dysrhythmias may predispose the occurrence of gastroesophageal reflux. We plan to use the recorder of esophageal pH and gastric electric potentials developed in Institute of Medical Engineering, National Taiwan University, combining with the unique design of simultaneous 24 hour ambulatory esophageal pH and EGG recordings and Matlab analysis of RSA-pH, to explore the relationship of gastric electric potentials and reflux esophagitis. Objectives: (1) Use simultaneous 24 hour ambulatory esophageal pH metry and EGG to integrate RSA and esophageal pH to explore whether a specific RSA prone to gastroesophageal reflux; or whether gastroesophageal reflux influence gastric electric activity; (2) Integrate RSA and esophageal pH with event of GI symptoms and daily activity to explore whether symptoms are resulted from acid reflux or gastric dysrhythmias. Materials and methods: Recruits 25 healthy and 25 previously diagnosed reflux esophagitis patients as volunteers to receive the followings: 1. GI and GERD symptom questionnaire with score of severity and frequency, and quality of life (QoL). 2. 24-hour ambulatory esophageal pH recording: total numbers of reflux episodes, total duration of pH \< 4 and DeMester score. They will be classified into: pathologic (pH \< 4, \> 4%且DeMeester score \> 14.72 ) and non-pathologic (pH \< 4, \< 4% and DeMeester score \< 14.72). 3. 24-hour ambulatory EGG recording: Use RSA to evaluate the quantity and quality of gastric electrical potentials. They will be classified into normal (3cpm), tachyrhythmia (\> 3cpm), and bradyrhythmia (\< 3cpm) three groups. 4. Use Matlab soft ware to integrate the data of simultaneous 24-hour esophageal pH value and RSA with events of symptoms and daily activities (meal time, postprandial, fasting, sleeping, and exercise).

Conditions

Interventions

TypeNameDescription
DEVICEEGG, 24 hour esophageal pH monitor

Timeline

Start date
2004-02-01
Completion
2005-08-01
First posted
2005-09-12
Last updated
2005-11-22

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT00154570. Inclusion in this directory is not an endorsement.